Zhongcheng Zhou
-
- Pluripotent Stem Cells Research 5
- CRISPR and Genetic Engineering 4
- Mitochondrial Function and Pathology 2
-
- Cancer-related molecular mechanisms research 4
-
- Telomeres, Telomerase, and Senescence 6
-
- SARS-CoV-2 and COVID-19 Research 4
-
- interferon and immune responses 3
-
- Tissue Engineering and Regenerative Medicine 2
Zhongcheng Zhou
35 papers receiving 474 citations
Peers
Comparison fields: 5 of 79
- Aging 11
- Molecular Biology 350
- Cancer Research 73
- Physiology 66
- Oncology 63
Countries citing papers authored by Zhongcheng Zhou
This map shows the geographic impact of Zhongcheng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongcheng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongcheng Zhou more than expected).
Fields of papers citing papers by Zhongcheng Zhou
This network shows the impact of papers produced by Zhongcheng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongcheng Zhou. The network helps show where Zhongcheng Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhongcheng Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 6 | |
| 10 | 2020 | 57 | |
| 11 | 2020 | 4 | |
| 12 | 2019 | 11 | |
| 13 | 2019 | 1 | |
| 14 | 2019 | 6 | |
| 15 | 2019 | 17 | |
| 16 | 2018 | 37 | |
| 17 | 2017 | 8 | |
| 18 | 2016 | 60 | |
| 19 | 2014 | 41 | |
| 20 | Wild-type p53 tumor suppressor gene restores differentiation of human squamous carcinoma cells but not the response to transforming growth factor beta. | 1993 | 22 |
About Zhongcheng Zhou
Zhongcheng Zhou is a scholar working on Aging, Cancer Research and Molecular Biology, having authored 39 papers that have together received 482 indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (6 papers), Pluripotent Stem Cells Research (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), CRISPR and Genetic Engineering (4 papers), Cancer-related molecular mechanisms research (4 papers), interferon and immune responses (3 papers), Mitochondrial Function and Pathology (2 papers) and Tissue Engineering and Regenerative Medicine (2 papers). The work is most often cited by research in Aging (11 citations), Molecular Biology (350 citations) and Cancer Research (73 citations). Zhongcheng Zhou has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Hua Wang, Lin Liu, Xiaoying Ye, Renpeng Guo, Jiameng Dan, Teresita Muñoz-Antonia, Jiao Yang, Junfang Xu, Lin Liu and Zhiqing Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.